SANTA CLARA, Calif. -- Anchiva Systems, Inc., a leading provider of Web security appliances for the enterprise, today announced its research lab, Rapid RxLabs, is now delivering over 700,000 signatures to detect and prevent malware from entering enterprise networks. Anchiva has a network of global honeypots, which collect viruses and a range of malware that are continuously monitored enabling frequent multiple updates daily to the signature base, providing its customers with the most complete web security threat response on the market today.
Anchivas Web Security Appliances have the ability to store more than one million signatures and currently holds over 700,000 malware signatures for long lasting protection against spyware and other malware with long lifecycles. Developed around Anchivas RapidRX ASIC high-speed data inspection engine and patent-pending malware identification techniques, Anchivas architecture scales to near gigabit rates and ensures secure Internet traffic in and out of corporate networks without impacting performance. Designed for enterprise organizations and service providers, Anchivas Web Security Appliances deliver a distinctive solution that scans the volumes of messages passing through network infrastructures while ensuring zero performance issues, or worse, slow down or stoppage of business operations.
The increase in Web 2.0 applications and technologies, and the potential financial gain hackers receive, attacks on Web applications will continue to rise. Enterprises looking to protect their networks at both inbound and outbound entry points need to have in-depth, application-centric, scanning and filtering capabilities to protect vital data. Anti-virus and anti-spyware signatures need to be updated frequently to protect companies against all threats while maintaining the pace of business. Having a security solution that addresses a complete range of security threats as well as performance needs is crucial to mission-critical, optimal business operations. Anchiva not only addresses these issues and threats, but does so at nearly 3 times faster than traditional software solutions.
Anchiva RapidRX Labs is one of the leading malware, anti-virus and vulnerability research organizations in the world, engaging the world's top researchers around the world. Anchiva RapidRX Labs combines world-class malicious code and anti-virus research with intrusion prevention and vulnerability expertise.
As the number and type of security risks companies are exposed to continues to grow at a rapid rate, the continuous delivery of additional malware signatures is critical to securing Web architectures in the enterprise said Charles Clark, CEO of Anchiva Systems. With the current availability of 700,000 malware signatures and the capability to scale to over a million signatures we are confident we are able to offer our customers one of the very best Web security appliances with both the broadest coverage and scalable performance architecture that blocks a complete range of malware.